P. Kelly Marcom

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian et al. · Journal of the National Comprehensive Cancer Network · 2018 · 1.6K citations · Full text

Nursing, Surgical Oncology, Breast Oncology +15

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Andrew D. Seidman, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2008 · 600 citations · Full text

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian et al. · Journal of the National Comprehensive Cancer Network · 2016 · 315 citations · Full text

Surgical Oncology, Breast Oncology, Health Sciences +14

Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer

Matthew J. Ellis, Feng Gao, Farrokh Dehdashti et al. · JAMA · 2009 · 302 citations · Full text

Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort

Rachel A. Greenup, Adam H. Buchanan, Wendy Lorizio et al. · Annals of Surgical Oncology · 2013 · 220 citations

Breast Oncology, Cancer Epidemiology, Medicine +12